Author

Robert Silva

Observed institutions: Kanazawa University, Lawrence Berkeley National Laboratory, Vanderbilt University, VA Palo Alto Health Care System, University of California San Diego, Massachusetts General Hospital, New England Center for Children, Archemix (United States), University Hospitals Cleveland Medical Center, IQVIA (United States), Sunovion (United States), Stanford Medicine, Sumitomo Dainippon Pharma (United States), Ipsen (United States), Pacific Consultants Co., Ltd. (Japan), Case Western Reserve University, University of California, Berkeley, Stanford University

OpenAlex ID: A5007892806

Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study

2013 · Antony Loebel, Josephine Cucchiaro, et al. · American Journal of Psychiatry · 343

Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study

2015 · Trisha Suppes, Robert Silva, et al. · American Journal of Psychiatry · 325

Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study

2013 · Antony Loebel, Josephine Cucchiaro, et al. · American Journal of Psychiatry · 294

Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study

2011 · Herbert Y. Meltzer, Josephine Cucchiaro, et al. · American Journal of Psychiatry · 251

Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent

2000 · James B. Rottman, Anthony J. Slavin, et al. · European Journal of Immunology · 204

Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study

2013 · Henry A. Nasrallah, Robert Silva, et al. · Journal of Psychiatric Research · 146

Long-term safety and tolerability of lurasidone in schizophrenia

2012 · Leslie Citrome, Josephine Cucchiaro, et al. · International Clinical Psychopharmacology · 122

Lurasidone for the Treatment of Irritability Associated with Autistic Disorder

2015 · Antony Loebel, Matthew Brams, et al. · Journal of Autism and Developmental Disorders · 117

PDF

Nobelium: Tracer Chemistry of the Divalent and Trivalent Ions

1968 · Jaromir Maly, Torbjorn Sikkeland, et al. · Science · 71

PDF

Chemical separation of rutherfordium

1970 · Robert Silva, James Harris, et al. · Inorganic and Nuclear Chemistry Letters · 70

PDF

Lurasidone in the Long‐term Treatment of Patients With Bipolar Disorder: a 24‐week Open‐label Extension Study

2016 · Terence A. Ketter, Kaushik Sarma, et al. · Depression and Anxiety · 69

PDF

Pharmacokinetics and Tolerability of Lurasidone in Children and Adolescents With Psychiatric Disorders

2015 · Robert L. Findling, Robert Goldman, et al. · Clinical Therapeutics · 53

Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study

2016 · Christoph U. Correll, Josephine Cucchiaro, et al. · CNS Spectrums · 50

PDF

Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia

2016 · Antony Loebel, Robert Silva, et al. · The Journal of Clinical Psychiatry · 44

Major depressive disorder with subthreshold hypomania (mixed features): Clinical characteristics of patients entered in a multiregional, placebo-controlled study

2016 · Steven D. Targum, Trisha Suppes, et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 30

Tracer chemical studies of lawrencium

1970 · Robert Silva, Torbjorn Sikkeland, et al. · Inorganic and Nuclear Chemistry Letters · 30

Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment

2017 · Andrei Pikalov, Joyce Tsai, et al. · International Journal of Bipolar Disorders · 29

PDF

Lurasidone in the Treatment of Acute Schizophrenia: Results of the Double-blind, Placebo-controlled Pearl 2 Trial

2010 · Josephine Cucchiaro, Robert Silva, et al. · Schizophrenia Research · 7

Efficacy of Lurasidone in Schizophrenia: Results of a Pooled Analysis Based on a 5-factor Model of Schizophrenia

2010 · Antony Loebel, Josephine Cucchiaro, et al. · Schizophrenia Research · 6

Phase 2 randomized study of abobotulinumtoxinA in patients with provoked vestibulodynia: dose-finding results

2025 · Andrew Goldstein, Rachel Rubin, et al. · The Journal of Sexual Medicine · 5

Pain Reduction With AbobotulinumtoxinA for the Treatment of Hallux Valgus in Adult Participants: Results of a Randomized and Placebo-Controlled Phase 2 Trial

2022 · David G. Armstrong, Lawrence A. DiDomenico, et al. · The Journal of Foot & Ankle Surgery · 4

Exploring the Relationship Between Clinical Presentation in Hallux Valgus and Response to AbobotulinumtoxinA Treatment

2023 · Babak Baravarian, Lawrence A. DiDomenico, et al. · The Journal of Foot & Ankle Surgery · 3

Poster #256 EFFECT OF LURASIDONE ON WEIGHT AND METABOLIC PARAMETERS: A COMPREHENSIVE DATABASE ANALYSIS

2012 · Andrei Pikalov, Josephine Cucchiaro, et al. · Schizophrenia Research · 3

AbobotulinumtoxinA in the management of hallux valgus in adult patients: Results of a randomized and placebo-controlled Phase II trial

2021 · Selene G. Parekh, David G. Armstrong, et al. · Toxicon · 2

AbobotulinumtoxinA in the Management of Hallux Valgus in Adult Patients: Results of a Randomised And Placebo-Controlled Phase 2 Trial

2020 · Robert Silva, Selene G. Parekh, et al. · Foot & Ankle Orthopaedics

PDF

Works count: 33

Citation count: 2,278

H-index: 17

I10-index: 17